
Qureight appoints Rebecca Simmons as Chief Operating Officer
Esme Needham | January 20, 2026 | Appointment | | Qureight, chief operating officer
Qureight has announced the appointment of Rebecca Simmons as Chief Operating Officer (COO).
Simmons brings more than two decades of operational leadership experience to her new role at Qureight. She most recently held the role of COO at Riverlane, during which time she drove significant growth for the company.
Her previous roles include Co-founder and Deputy Director of The Healthcare Improvement Studies (THIS) Institute, COO at 52North and Chair of the International Advisory Board of the Danish Diabetes and Endocrine Academy.
As COO of Qureight, Simmons aims to lead sustainable growth for the company through a key period of scaling and expansion.
Qureight is a techbio company using its AI-driven computed tomography (CT) imaging biomarkers and clinical data management platform to improve the landscape of clinical trials and accelerate successful drug development.
Muhunthan Thillai, co-founder and CEO of Qureight, said: “Rebecca’s experience, expertise and people-centric leadership approach will be instrumental in supporting the team as we scale the company, accelerating our mission to advance understanding of lung and heart disease. Her blend of rigorous academic training with commercial acumen made Rebecca the natural choice to lead this next chapter of growth for Qureight.”
Simmons added: “Qureight’s pioneering AI-powered CT imaging biomarkers and data management platform is enabling real insights to be drawn from complex and diverse health data, to ultimately deliver real impact for patients.”






